Website stats for Pharmastrategyblog - pharmastrategyblog.com
pharmastrategyblog.com was registered 1 decade 6 years ago. It is a domain having .com extension. It is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently, pharmastrategyblog.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | Not Applicable |
| Daily Pageviews: | Not Applicable |
Estimated Valuation
| Income Per Day: | $ 0.15 |
| Estimated Worth: | $ 8.95 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | Not Applicable |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
104.197.56.171
Hosted Country:
US
Location Latitude:
41.2619Location Longitude:
-95.8608Search Engine Results For pharmastrategyblog.com
Top 10 Pharma Blogs 2016 - LinkedIn
Nov 17, 2016 ... Pharma Strategy Blog. This blog is created and maintained by Sally Church, Ph.D., who is an English biochemist with special interests on ...
Hans Skov – CEO – Pharmaceutical Consulting Services | LinkedIn
Blog: http://pharmastrategyblog.com/ Eksternt link. Hans. Bliv medlem for at se hele Hans' profil. Vis hele profilen ...
Enzalutamide for patients with metastatic castration-resistant ......
Apr 17, 2015 ... Abiraterone now Approved as Zytiga by the FDA for Castrate Resistant Prostate Cancer: Pharma Strategy Blog. 2011.
Aligning the Economic Value of Companion Diagnostics and ... - NCBI
Available online: http://pharmastrategyblog.com/2011/08/my-take-on-the-crizotinibxalkori-fda-approval.html/. 25. Herper M. Gene Test for Pfizer Cancer Drug ...
About - Molquant
Pharma Strategy Blog Feb. 25, 2013 "Will Biomarkers Revolutionize Treatment with Tivozanib?" Genetic Engineering News (GEN) Oct. 1, 2012 "Animal Models Get ...
A large scale high-throughput screen identifies chemical inhibitors...
Targeting Wnt signaling, therefore, is a priority for several pharmacological companies (20, 25) (see also http://pharmastrategyblog.com/2010/09/wnt-signaling- ...
What are the best biotech sites/forums/resources? - Quora
Sally Church - Pharma Strategy Blog. Bruce Booth, Atlas Venture Partner - http://lifescivc.com. Alexey Barnesev's Stem Cell Assays.
Understanding NHL - Beating Back Cancer
- http://beatingbackcancer.blogspot.com/2010/04/understanding-nhl.html
Apr 18, 2010 ... ... #ASH09 meeting report: Non-Hodgkins Lymphoma (pharmastrategyblog.com); Spectrum Pharmaceuticals Announces Fourth Quarter and Fiscal Year ...
PGTandMe: Social Networking-Based Genetic Testing and the ...
44 Research Revolution—23AndMe, PHARMA STRATEGY BLOG (Aug. 20,. 2009), http://pharmastrategyblog.com/2009/08/research-revolution-23andme.html/.
มารู้จักมะเร็งกันดีกว่าค่ะ ^^ รู้เขารู้เรา รบร้อยครั้ง ชนะร้อยครั้ง...
ภาพจาก http://www.pharmastrategyblog.com/2008/05/index.html. มะเร็ง คือกลุ่มของโรคที่เกิดจากเซลล์ของร่างกายมีความผิดปกติ ส่งผลให้เซลล์มีการเจริญเติบโต มี ...
www.pharmastrategyblog.vg/
Kurt Hiller - POETA y Ciencia
- https://josemariamedina05.wordpress.com/tag/kurt-hiller/
Mar 30, 2013 ... Novel medical education possibilities for Pharma based on technology(pharmastrategyblog.com) · Tcp1 mary miyoshi pedroza garcía (slideshare.net) ...
Six Ways to Promote Your Health Care Blog - Health JAM
Mar 29, 2012 ... Sally Church (Pharma Strategy Blog). Derek Lowe (In the Pipeline). John Mack (Pharma Marketing Blog). Ed Silverman (Pharmalot).
Semantic Web meets Competitive Intelligence
http://www.pharmastrategyblog.com/2009/01 [Accessed October 2009]. [39] SciTech Library Question. Available at http://stlq.info/ [Accessed October 2009].
January 2010 - Oh My Aches and Pains!
Jan 29, 2010 ... ... #ASH09 Report: Acute Myeloid Leukemia (pharmastrategyblog.com); Scientists Find New Leukemia Gene Risk Factors (nlm.nih.gov).
Things I Won't Work With: Azidoazide Azides, More Or Less. I...
Jan 9, 2013 ... Pharma Strategy Blog. No Name No Slogan. Practical Fragments. SimBioSys. The Curious Wavefunction. Natural Product Man. Fragment Literature.
Vemurafenib, Zelboraf - Cánceres Información
Jan 21, 2012 ... http://pharmastrategyblog.com/2011/06/bms-and-roche-join-forces-in-metastatic-melanoma.html/. Cánceres indicados:.
Top 50 Pharma Blogs & Websites For Indian Pharma students
Pharma Strategy Blog: Sally Church, PhD of Icarus Consultants provides business insights into the pharmaceuticals industry here.
IAmA cancer researcher. AMA. - Reddit
http://pharmastrategyblog.com/2011/01/plx4032-phase-iii-data-in-metastatic-melanoma-announced-by-roche.html/. Upvote 1. Downvote. Reply. u/twitch523 avatar ...
Cáncer de páncreas Dr. Roberto delgado R2MI. - SlidePlayer
http://www. pharmastrategyblog http://www.pharmastrategyblog.com/2010/01/asco-early-detection-of-pancreatic-cancer-using-pam4-as-a-biomarker.html.
Do cell phones lead to brain tumors? - thecancergeek
- https://thecancergeek.wordpress.com/2011/06/01/do-cell-phones-lead-to-brain-tumors/
Jun 1, 2011 ... ... Repairman's Science Blog · Image Goddess · Jody Schoger, Cancer Survivor and Advocate · Julie @ Sugar Scientist · Pharma Strateg...
Treatment and stability of Class II Division 2 malocclusion in...
Jul 5, 2022 ... [18] Pharma Strategy Blog. The increasing use of social media to ... http://pharmastrategyblog.com/2009/11/the-increasing-use-of-social-.
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 13 | H2 Headings: | Not Applicable |
| H3 Headings: | Not Applicable | H4 Headings: | 4 |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 15 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Server: nginx
Date: Sat, 20 Aug 2022 18:54:00 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Keep-Alive: timeout=20
Vary: Accept-Encoding,Cookie
Link:
X-Powered-By: WP Engine
X-Cacheable: SHORT
Cache-Control: max-age=600, must-revalidate
X-Cache: HIT: 1
X-Cache-Group: normal
Content-Encoding: gzip
Domain Information
| Domain Registrar: |
Tucows Domains Inc.
|
|---|---|
| Registration Date: | 2008-09-07 1 decade 6 years 8 months ago |
| Last Modified: | 2022-06-26 2 years 10 months 2 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.hover.com | |
216.40.47.26 |  Canada |
| ns2.hover.com | |
64.98.148.13 | Canada |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| pharmastrategyblog.com | A | 295 |
IP: 104.197.56.171 |
| pharmastrategyblog.com | NS | 900 |
Target: ns1.hover.com |
| pharmastrategyblog.com | NS | 900 |
Target: ns2.hover.com |
| pharmastrategyblog.com | SOA | 900 |
MNAME: ns1.hover.com RNAME: dnsmaster.hover.com Serial: 1326465106 Refresh: 10800 Retry: 3600 Expire: 604800 |
| pharmastrategyblog.com | MX | 300 |
Priority: 10 Target: ALT4.ASPMX.L.GOOGLE.com |
| pharmastrategyblog.com | MX | 300 |
Priority: 5 Target: ALT1.ASPMX.L.GOOGLE.com |
| pharmastrategyblog.com | MX | 300 |
Priority: 5 Target: ALT2.ASPMX.L.GOOGLE.com |
| pharmastrategyblog.com | MX | 300 |
Priority: 1 Target: ASPMX.L.GOOGLE.com |
| pharmastrategyblog.com | MX | 300 |
Priority: 10 Target: ALT3.ASPMX.L.GOOGLE.com |
Full WHOIS Lookup
Registry Domain ID:
1518234111_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.tucows.com
Registrar URL: http://www.tucows.com
Updated
Date: 2022-06-25T16:20:19Z
Creation Date:
2008-09-06T21:26:03Z
Registry Expiry Date:
2025-09-06T21:26:03Z
Registrar: Tucows Domains Inc.
Registrar
IANA ID: 69
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.4165350123
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS1.HOVER.COM
Name Server: NS2.HOVER.COM
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2022-08-20T18:53:34Z
Similarly Ranked Websites
Google Chrome - Download the Fast, Secure Browser from Google
Get more done with the new Google Chrome. A more simple, secure, and faster web browser than ever, with Google’s smarts built-in. Download now.
1 
$ 16,097,351,400.00
Log into Facebook
Log into Facebook to start sharing and connecting with your friends, family, and people you know.
4 $ 4,024,338,120.00
腾讯网
腾讯网从2003年创立至今，已经成为集新闻信息，区域垂直生活服务、社会化媒体资讯和产品为一体的互联网媒体平台。腾讯网下设新闻、科技、财经、娱乐、体育、汽车、时尚等多个频道，充分满足用户对不同类型资讯的需求。同时专注不同领域内容，打造精品栏目，并顺应技术发展趋势，推出网络直播等创新形式，改变了用户获取资讯的方式和习惯。
4 $ 4,024,338,120.00
Amazon.com. Spend less. Smile more.
- amazon.com
Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and...
7 $ 2,299,621,320.00